The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to new research. The disease, known as metabolic dysfunction-associated ...

Non-alcoholic fatty liver disease is the leading chronic liver disease affecting many non-drinkers in India. Early detection ...

Results from the ESSENCE Phase III clinical trial published in the New England Journal of Medicine show treating patients with semaglutide can halt and even reverse liver disease. The ...

Previously known as non-alcoholic fatty liver disease (NAFLD), metabolic dysfunction-associated steatotic liver disease is common in older adults. As people age, they often experience increased ...

But when the liver gets hurt again and again — as with alcohol-induced liver disease (ARLD) — these very cells begin to break down. Instead of dampening the immune response, they start to exacerbate ...

When administered for 48 weeks, the SGLT2 inhibitor dapagliflozin alleviated steatohepatitis and fibrosis in patients with metabolic dysfunction-associated steatohepatitis (MASH) while demonstrating a ...

Researchers at the University of Missouri found that diet and exercise can significantly improve liver disease caused by too much fat buildup. They had one group of patients with liver disease follow ...

What Is Metabolic Dysfunction-Associated Steatohepatitis? Metabolic dysfunction-associated steatohepatitis, or MASH, is a form of liver disease. MASH occurs when fat accumulates in liver cells. Plenty ...

Fatty liver disease (also called steatotic liver disease) happens when too much fat builds up in your liver. It can be caused by high alcohol use or metabolic syndrome (a group of conditions like ...

Semaglutide was found to reduce liver inflammation and liver scarring. The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to new ...